These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 11574355

  • 1. The effect of timing of dolasetron administration on its efficacy as a prophylactic antiemetic in the ambulatory setting.
    Chen X, Tang J, White PF, Wender RH, Quon R, Sloninsky A, Naruse R, Kariger R, Webb T, Norel E.
    Anesth Analg; 2001 Oct; 93(4):906-11. PubMed ID: 11574355
    [Abstract] [Full Text] [Related]

  • 2. A comparison of the costs and efficacy of ondansetron versus dolasetron for antiemetic prophylaxis.
    Zarate E, Watcha MF, White PF, Klein KW, Sa Rego M, Stewart DG.
    Anesth Analg; 2000 Jun; 90(6):1352-8. PubMed ID: 10825320
    [Abstract] [Full Text] [Related]

  • 3. Ondansetron and dolasetron provide equivalent postoperative vomiting control after ambulatory tonsillectomy in dexamethasone-pretreated children.
    Sukhani R, Pappas AL, Lurie J, Hotaling AJ, Park A, Fluder E.
    Anesth Analg; 2002 Nov; 95(5):1230-5, table of contents. PubMed ID: 12401599
    [Abstract] [Full Text] [Related]

  • 4. Intravenous dolasetron for the prevention of postoperative nausea and vomiting after outpatient laparoscopic gynecologic surgery.
    Graczyk SG, McKenzie R, Kallar S, Hickok CB, Melson T, Morrill B, Hahne WF, Brown RA.
    Anesth Analg; 1997 Feb; 84(2):325-30. PubMed ID: 9024022
    [Abstract] [Full Text] [Related]

  • 5. Treatment of postoperative nausea and vomiting with single intravenous doses of dolasetron mesylate: a multicenter trial. Dolasetron Mesylate PONV Treatment Study Group.
    Kovac AL, Scuderi PE, Boerner TF, Chelly JE, Goldberg ME, Hantler CB, Hahne WF, Brown RA.
    Anesth Analg; 1997 Sep; 85(3):546-52. PubMed ID: 9296407
    [Abstract] [Full Text] [Related]

  • 6. Oral dolasetron mesylate for prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study. The Oral Dolasetron PONV Prevention Study Group.
    Diemunsch P, Korttila K, Leeser J, Helmers JH, Wilkey B, Navé S, Radke AJ, Hahne WF, Brown RA.
    J Clin Anesth; 1998 Mar; 10(2):145-52. PubMed ID: 9524901
    [Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness of prophylactic dolasetron or droperidol vs rescue therapy in the prevention of PONV in ambulatory gynecologic surgery.
    Frighetto L, Loewen PS, Dolman J, Marra CA.
    Can J Anaesth; 1999 Jun; 46(6):536-43. PubMed ID: 10391600
    [Abstract] [Full Text] [Related]

  • 8. [Prophylaxis of nausea and vomiting after thyroid surgery: comparison of oral and intravenous dolasetron with intravenous droperidol and placebo].
    Danner K, Becker HG, Best B, Madler C.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Jul; 36(7):425-30. PubMed ID: 11496617
    [Abstract] [Full Text] [Related]

  • 9. Antiemetic prophylaxis for office-based surgery: are the 5-HT3 receptor antagonists beneficial?
    Tang J, Chen X, White PF, Wender RH, Ma H, Sloninsky A, Naruse R, Kariger R, Webb T, Zaentz A.
    Anesthesiology; 2003 Feb; 98(2):293-8. PubMed ID: 12552184
    [Abstract] [Full Text] [Related]

  • 10. Dolasetron for the prevention of postoperative nausea and vomiting following outpatient surgery with general anaesthesia: a randomized, placebo-controlled study. The Dolasetron PONV Prevention Study Group.
    Philip BK, Pearman MH, Kovac AL, Chelly JE, Wetchler BV, McKenzie R, Monk TG, Dershwitz M, Mingus M, Sung YF, Hahne WF, Brown RA.
    Eur J Anaesthesiol; 2000 Jan; 17(1):23-32. PubMed ID: 10758440
    [Abstract] [Full Text] [Related]

  • 11. Timing of administration of dolasetron affects dose necessary to prevent postoperative nausea and vomiting.
    Korttila KT, Jokinen JD.
    J Clin Anesth; 2004 Aug; 16(5):364-70. PubMed ID: 15374558
    [Abstract] [Full Text] [Related]

  • 12. Pooled analysis of three large clinical trials to determine the optimal dose of dolasetron mesylate needed to prevent postoperative nausea and vomiting. The Dolasetron Prophylaxis Study Group.
    Philip BK, McLeskey CH, Chelly JE, McKenzie R, Kovac AL, Diemunsch P, DuBois DM.
    J Clin Anesth; 2000 Feb; 12(1):1-8. PubMed ID: 10773500
    [Abstract] [Full Text] [Related]

  • 13. Dolasetron versus ondansetron for the treatment of postoperative nausea and vomiting.
    Meyer TA, Roberson CR, Rajab MH, Davis J, McLeskey CH.
    Anesth Analg; 2005 Feb; 100(2):373-377. PubMed ID: 15673860
    [Abstract] [Full Text] [Related]

  • 14. Prophylactic oral dolasetron mesylate reduces nausea and vomiting after abdominal hysterectomy. The Canadian Dolasetron Study Group.
    Warriner CB, Knox D, Belo S, Cole C, Finegan BA, Perreault L.
    Can J Anaesth; 1997 Nov; 44(11):1167-73. PubMed ID: 9398956
    [Abstract] [Full Text] [Related]

  • 15. [Dolasetron, droperidol and a combination of both in prevention of postoperative nausea and vomiting after extracapsular cataract extraction under general anesthesia].
    Eberhart LH, Lindenthal M, Seeling W, Gäckle H, Georgieff M.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Jun; 34(6):345-9. PubMed ID: 10429772
    [Abstract] [Full Text] [Related]

  • 16. [Prevention of post-operative nausea and vomiting. Randomised comparison of dolasetron versus dolasetron plus dexamethasone].
    Piper SN, Triem JG, Röhm KD, Kranke P, Maleck WH, Boldt J.
    Anaesthesist; 2003 Feb; 52(2):120-6. PubMed ID: 12624696
    [Abstract] [Full Text] [Related]

  • 17. The effect of timing of ondansetron administration on its efficacy, cost-effectiveness, and cost-benefit as a prophylactic antiemetic in the ambulatory setting.
    Tang J, Wang B, White PF, Watcha MF, Qi J, Wender RH.
    Anesth Analg; 1998 Feb; 86(2):274-82. PubMed ID: 9459232
    [Abstract] [Full Text] [Related]

  • 18. Intravenous dolasetron mesilate ameliorates postoperative nausea and vomiting.
    Diemunsch P, Leeser J, Feiss P, D'Hollander A, Bradburn BG, Paxton D, Whitmore J, Panouillot P, Navé S, Brown RA, Hahne WF.
    Can J Anaesth; 1997 Feb; 44(2):173-81. PubMed ID: 9043731
    [Abstract] [Full Text] [Related]

  • 19. Intravenous dolasetron and ondansetron in prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study.
    Korttila K, Clergue F, Leeser J, Feiss P, Olthoff D, Payeur-Michel C, Wessel P, Nave S, Hahne W, Brown R.
    Acta Anaesthesiol Scand; 1997 Aug; 41(7):914-22. PubMed ID: 9265937
    [Abstract] [Full Text] [Related]

  • 20. Intravenous dolasetron mesilate in the prevention of postoperative nausea and vomiting in females undergoing gynecological surgery.
    Diemunsch P, D'Hollander A, Paxton L, Schoeffler P, Wessel P, Navé S, Brown RA, Hahne WF.
    J Clin Anesth; 1997 Aug; 9(5):365-73. PubMed ID: 9257201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.